E
Talis Biomedical Corporation TLIS
$1.60 -$0.08-4.76%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2024 03/31/2024 12/31/2023 09/30/2023 06/30/2023
Revenue -- -94.01% -24.12% -82.41% 1.57%
Total Other Revenue -- -- -- -- --
Total Revenue -- -94.01% -24.12% -82.41% 1.57%
Cost of Revenue -84.84% -81.62% -54.20% -55.71% -43.42%
Gross Profit 83.96% 80.43% 54.65% 54.52% 44.84%
SG&A Expenses 24.45% 4.39% -8.34% -0.25% -30.16%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -43.57% -54.40% -40.87% -37.96% -39.05%
Operating Income 41.57% 51.86% 41.04% 36.64% 39.90%
Income Before Tax 41.14% 26.90% 50.02% 39.73% 44.34%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 41.14% 26.90% 50.02% 39.73% 44.34%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 41.14% 26.90% 50.02% 39.73% 44.34%
EBIT 41.57% 51.86% 41.04% 36.64% 39.90%
EBITDA 41.48% 52.80% 32.03% 26.71% 38.30%
EPS Basic 41.31% 27.27% 50.28% 40.32% 44.88%
Normalized Basic EPS 41.31% 55.01% 42.63% 40.32% 44.88%
EPS Diluted 41.31% 27.27% 50.28% 40.32% 44.88%
Normalized Diluted EPS 41.31% 55.01% 42.63% 40.32% 44.88%
Average Basic Shares Outstanding 0.28% 0.52% 0.54% 0.98% 0.98%
Average Diluted Shares Outstanding 0.28% 0.52% 0.54% 0.98% 0.98%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings